Discover 3,557 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,557
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
for
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia
Location: Orange CA, Irvine CA, Houston TX, Canton OH, Miami FL,
Sponsor: Hoth Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05639933
Phase2, Recruiting
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
for
Advanced Refractory Solid Tumors,
Location: California City CA, Colorado Springs CO, Texas City TX,
Sponsor: Cosmo Technologies Ltd
Sex: All
Age: 18+
Code: NCT03863145
Early_phase1, Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Orange CA, Santa Monica CA, Salt Lake City UT,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05379985
Phase1, Phase2, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Orange CA, Los Angeles CA, Gilbert AZ, San Francisco CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase1, Recruiting
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Orange CA, Irvine CA, Costa Mesa CA, Laguna Hills CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
for
Metastatic Urothelial Carcinoma,
Location: Orange CA, Irvine CA, Duarte CA, La Jolla CA, Dallas TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06439836
Phase1, Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Orange CA, Irvine CA, Yorba Linda CA, Long Beach CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase3, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Orange CA, Irvine CA, Los Angeles CA, Las Vegas NV,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Orange CA, Irvine CA, Anaheim CA, Costa Mesa CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Orange CA, Irvine CA, Torrance CA, Beverly Hills CA,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Orange CA, Irvine CA, Los Angeles CA, Beverly Hills CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase2, Recruiting
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
for
Advanced Hepatocellular Carcinoma,
Location: Orange CA, Irvine CA, Portland OR, Pittsburgh PA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06811116
Phase1, Phase2, Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
for
Grade 2 Meningioma, Intracranial Meningioma
Location: Orange CA, Anaheim CA, Bellflower CA, Ontario CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT03180268
Phase3, Recruiting
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Orange CA, Irvine CA, Anaheim CA, Bellflower CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500455
Phase3, Recruiting
mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer
for
Urothelial Bladder Cancer, Muscle-Invasive Bladder Cancer
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06335667
Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Orange CA, Irvine CA, Beverly Hills CA, Los Angeles CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05673148
Phase2, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Orange CA, Irvine CA, Burbank CA, Palo Alto CA, Napa CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase3, Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
for
Metastatic Malignant Neoplasm in the Liver,
Location: Orange CA, Irvine CA, Huntington Beach CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05040360
Phase2, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer